Prot# VX03-497-205: A Phase 2b Study of Merimepodib in Combination with Pegylated Interferon Alfa-2a (Pegasys®) and Ribavirin in Subjects with Chronic Genotype 1 Hepatitis C Non-Responsive to Prior Therapy with Pegylated Interferon Alfa and Ribavirin

Project: Research project

Project Details

StatusFinished
Effective start/end date12/7/048/10/10

Funding

  • Covance Periapproval Services, Inc. (VX03-497-205)
  • Vertex Pharmaceuticals Incorporated (VX03-497-205)